Dana Pepe, MD

Medical Director and Associate Hospital Epidemiologist
Beth Israel Deaconess Medical Center/Harvard Medical School

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1786 - Characterizing Antibiotic Use in Patients with Hematologic and Oncologic Malignancies Transitioned to Comfort Measures Only (CMO) During Hospital Admission
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET